Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.2, 2003-01, pp. : 75-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke: A Canadian Healthcare Perspective

By Sinclair S.E.

PharmacoEconomics, Vol. 19, Iss. 9, 2001-01 ,pp. : 927-936

Adis International

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

By Igarashi Ataru

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries

By Liu Bao Peng Chong Qing Tan Xiao Min Wan Cui Wei

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 619-619

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach

By Vanagas Giedrius Padaiga Zilvinas Bagdonas Eugenijus

Substance Use & Misuse, Vol. 41, Iss. 1, 2006-06 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite